Abstract | OBJECTIVE: DESIGN: Retrospective chart review. PARTICIPANTS: One hundred and ninety two eyes of 184 patients. METHODS: RESULTS: CONCLUSIONS:
|
Authors | Claudine Bellerive, Benoît Cinq-Mars, Gilles Lalonde, Mario Malenfant, Eric Tourville, Yvon Tardif, Marcelle Giasson, Marc Hébert |
Journal | Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
(Can J Ophthalmol)
Vol. 47
Issue 2
Pg. 165-9
(Apr 2012)
ISSN: 1715-3360 [Electronic] England |
PMID | 22560423
(Publication Type: Comparative Study, Journal Article)
|
Copyright | Copyright © 2012 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Angiogenesis Inhibitors
- Antibodies, Monoclonal, Humanized
- VEGFA protein, human
- Vascular Endothelial Growth Factor A
- Bevacizumab
- Ranibizumab
|
Topics |
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors
(administration & dosage, adverse effects)
- Antibodies, Monoclonal, Humanized
(administration & dosage, adverse effects)
- Bevacizumab
- Female
- Humans
- Intravitreal Injections
- Male
- Middle Aged
- Needs Assessment
- Ranibizumab
- Retrospective Studies
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A
(antagonists & inhibitors)
- Visual Acuity
(physiology)
- Wet Macular Degeneration
(drug therapy, physiopathology)
|